NCT04221906 - Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

March 6, 2020

Study Completion Date

March 6, 2020

Conditions

Chronic Plaque Psoriasis

Interventions

DRUG

BOS-475

topical cream

DRUG

Active ingredient-free vehicle cream

topical cream

DRUG

Daivonex cream (calcipotriol 0.005%)

topical cream

DRUG

Betnesol-V cream (betamethasone 0.1%)

topical cream

Trial Locations (3)

Gemeinschaftspraxis Dr. med. Johannes Niesmann und Dr. med. Nick Othlinghaus Hauszentrum im Jahrhunderthaus - Zentrum für klinische Studien, Bochum

bioskin GmbH, Hamburg

Klinische Forschung Schwerin GmbH, Schwerin